cyclopentenyluracil has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cysyk, RI; Lim, MI; Marquez, VE; Moyer, JD | 1 |
| August, EM; Cysyk, RL; Malinowski, N; Marquez, V; Moyer, JD; Zaharevitz, D | 1 |
2 other study(ies) available for cyclopentenyluracil and Leukemia L 1210
| Article | Year |
|---|---|
Cyclopentenyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase.
Topics: Animals; Binding, Competitive; Cell Division; Cytidine; Indicators and Reagents; Kinetics; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Optical Rotation; Phosphotransferases; Structure-Activity Relationship; Uridine; Uridine Kinase | 1984 |
Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo.
Topics: Animals; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrimidine Nucleotides; Uracil; Uracil Nucleotides; Uridine; Uridine Kinase | 1995 |